Suppr超能文献

人类糖尿病神经病变中的神经内膜微血管。内皮细胞功能障碍及醛糖还原酶抑制剂的治疗无效。

Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor.

作者信息

Sima A A, Nathaniel V, Prashar A, Bril V, Greene D A

机构信息

Department of Pathology, University of Manitoba, Winnipeg, Canada.

出版信息

Diabetes. 1991 Sep;40(9):1090-9. doi: 10.2337/diab.40.9.1090.

Abstract

Endoneurial microvascular abnormalities have been invoked in the pathogenesis of diabetic distal symmetric polyneuropathy. Detailed morphometric analysis of the endoneurial microvasculature was correlated with previously published data on nerve fiber morphometry and teased fiber analysis obtained from the same sural nerve biopsies. Biopsy specimens from neuropathic diabetic patients were obtained before and after 12 mo of aldose reductase inhibitor (ARI) treatment and compared to 15 carefully age-matched control subjects. Diabetic microvessels showed basement membrane thickening and loss of endothelial cell tight junctions. Microvascular density and the frequency of microvessels closed by endothelial cells increased with age in diabetic and control nerves and were unaffected by diabetes. The density of microvessels showing patent lumina did not differ between control and diabetic subjects and was not related to age or diabetes. Closed microvessels were composed of postcapillary venules that were otherwise devoid of ultrastructural abnormalities. We suggest that microvascular closure by endothelial cells may be a physiological condition and is unlikely to have any pathogenetic significance in diabetic neuropathy. Based on the current limited biopsy material, we conclude that 12 mo of ARI treatment that induced significant fiber repair and regeneration had no detectable effect on endoneurial microvascular abnormalities. These data suggest that endoneurial vascular pathology is not a rate-limiting factor in fiber damage or repair at this stage of diabetic neuropathy.

摘要

神经内膜微血管异常已被认为与糖尿病性远端对称性多发性神经病变的发病机制有关。对神经内膜微血管系统进行详细的形态计量分析,并与先前发表的关于从相同腓肠神经活检标本中获得的神经纤维形态计量学和单纤维分析数据相关联。在接受醛糖还原酶抑制剂(ARI)治疗12个月之前和之后,获取神经性糖尿病患者的活检标本,并与15名年龄匹配的对照受试者进行比较。糖尿病微血管显示基底膜增厚和内皮细胞紧密连接丧失。在糖尿病神经和对照神经中,微血管密度以及被内皮细胞封闭的微血管频率随年龄增加,且不受糖尿病影响。显示管腔通畅的微血管密度在对照受试者和糖尿病受试者之间没有差异,并且与年龄或糖尿病无关。封闭的微血管由毛细血管后微静脉组成,这些微静脉在其他方面没有超微结构异常。我们认为内皮细胞导致的微血管封闭可能是一种生理状况,在糖尿病神经病变中不太可能具有任何致病意义。基于目前有限的活检材料,我们得出结论,诱导显著纤维修复和再生的12个月ARI治疗对神经内膜微血管异常没有可检测到的影响。这些数据表明,在糖尿病神经病变的这个阶段,神经内膜血管病变不是纤维损伤或修复的限速因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验